Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Satellos Bioscience Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $143.66M | $143.66M - $143.66M | $0.00 | -$0.89 | 3 |
| Dec 2029 | $63.31M | $63.31M - $63.31M | $0.00 | -$2.417 | 5 |
| Dec 2028 | $19.87M | $19.87M - $19.87M | $0.00 | -$2.84 | 6 |
| Dec 2027 | $0.00 | $0.00 - $0.00 | $0.00 | -$2.998 | 0 |
| Dec 2026 | $0.00 | $0.00 - $0.00 | $0.00 | -$2.878 | 0 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.785 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$2.729 | 0 |
| Dec 2022 | $134.5K | $134.5K - $134.5K | $0.00 | -$0.242 | 1 |